Perturbations in Respiratory Syncytial Virus Activity During the SARS-CoV-2 Pandemic.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36315855.
- Also identified by DOI 10.1093/infdis/jiac434.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Respiratory syncytial virus (RSV) is a common cause of respiratory disease in all age groups, with young children and older adults experiencing the most severe illness. The coronavirus disease 2019 (COVID-19) pandemic resulted in striking changes in the activity of seasonal respiratory viruses, including RSV. After a period of suppression early in the pandemic, an interseasonal surge of RSV occurred in 2021. Viral activity was detected primarily in children and young adults after relaxation of public health measures, but without the usual proportional increases in infections and hospitalizations in older adults who were likely still adhering to stricter public health measures.
Medical subject headings
- Respiratory Syncytial Virus Infections
- Respiratory Tract Infections
- COVID-19
- Respiratory Syncytial Virus, Human